Evaluation of drug-excipient interaction in the formulation of celecoxib tablets

Acta Poloniae Pharmaceutica - Drug Research

Volumn 68, Issue 3, 2011, Pages 423-433

  Bozdaǧ Pehlivan, Sibel ^a   Subaşi, Birsel ^a,b   Vural, Imran ^a   Ünlü, Nurşen ^a   Çapan, Yilmaz ^a  

^a HACETTEPE UNIVERSITY   (Turkey)

^b Refik Saydam National Public Health Agency   (Turkey)

Author keywords

Caco 2 cells; Celecoxib; Drug excipient interaction; Permeability

Indexed keywords

CELECOXIB; EXCIPIENT; MAGNESIUM STEARATE; SILICON DIOXIDE; WATER;

AQUEOUS SOLUTION; ARTICLE; DRUG FORMULATION; DRUG PENETRATION; DRUG SCREENING; DRUG SOLUBILITY; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; INFRARED SPECTROSCOPY; TABLET FORMULATION;

CACO-2 CELLS; CALORIMETRY, DIFFERENTIAL SCANNING; CELLULOSE; CHEMISTRY, PHARMACEUTICAL; CHROMATOGRAPHY, HIGH PRESSURE LIQUID; CYCLOOXYGENASE 2 INHIBITORS; DRUG COMPOUNDING; DRUG STABILITY; EXCIPIENTS; HUMANS; HUMIDITY; INTESTINAL ABSORPTION; INTESTINAL MUCOSA; LACTOSE; PERMEABILITY; POVIDONE; PYRAZOLES; SILICON DIOXIDE; SOLUBILITY; SPECTROSCOPY, FOURIER TRANSFORM INFRARED; STEARIC ACIDS; SULFONAMIDES; TABLETS; TALC; TECHNOLOGY, PHARMACEUTICAL; TEMPERATURE; TIME FACTORS;

EID: 79956314437     PISSN: 00016837     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (28)

1. Verma R.K., Garg S.: J. Pharm. Biomed. Anal. 38, 633 (2005).
2. Batista De Carvalho L.A.E., Marques M.P.M., Tomkinson J.: Biopolymers 82, 420 (2006).
3. Vueba M.L., Batista De Carvalho L.A.E., Veiga F., Sousa J.J., Pina M.E.: Drug Dev. Ind. Pharm. 31, 653 (2005).
4. Bruni G., Amici L., Berbenni V., Marini A., Orlandi A.: J. Therm. Anal. Cal. 68, 561 (2002).
5. Wyttenbach N., Birringer C., Alsenz J., Kuentz M.: Pharm. Dev. Technol. 10, 499 (2005).
6. Verma R.K., Garg S. : J. Pharm. Biomed. Anal. 35, 449 (2004).
7. Nagarsenker M.S., Joshi M.S.: Drug Dev. Ind. Pharm. 31, 169 (2005).
8. Shah P., Jogani V., Bagchi T., Misra A.: Biotechnol. Prog. 22, 186 (2006).
9. Hidalgo I.J., Raub T.J., Borchardt R.T.: Gastroenterology 96, 736 (1989).
10. Abdel-Hamid M., Novotny L., Hamza H.: J. Chromatogr. B Biomed. Sci. Appl. 753, 401 (2001).
11. Kumar V., Shah R.P., Malik S., Singh S.: J. Pharm. Biomed. Anal. 49, 880 (2009).
12. Thakkar H., Sharma R.K., Mishra A.K., Chuttani K., Murthy R.R.: AAPS Pharm. Sci. Tech. 6, E65 (2005).
13. Thakkar H., Sharma R.K., Mishra A.K., Chuttani K., Murthy R.S.: J. Drug Target. 12, 549 (2004).
14. Han H.K., Oh D.M., Amidon G.L.: Pharm. Res. 15, 1382 (1998).
15. Bebawy L.I., Moustafa A.A., Abo-Talib N.F.: J. Pharm. Biomed. Anal. 27, 779 (2002).
16. Sinha V.R., Anitha R., Ghosh S., Nanda A., Kumria R.: J. Pharm. Sci. 94, 676 (2005).
17. Late S.G., Banga A.K.: Pharmazie 63, 453 (2008).
18. Williams R.O., Reynolds T.D., Cabelka T.D., Sykora M.A., Mahaguna V.: Pharm. Dev. Technol. 7, 181 (2002).
19. Ford J.L., Rubenstein M.H., McCaul F., Hogan J.E., Edger P.J.: Int. J. Pharm. 40, 223 (1987).
20. Kuno Y., Kojima M., Nakagami H., Yonemochi E., Terada K.: Eur. J. Pharm. Biopharm. 69, 986 (2008).
21. Fassihi R.A., McPhillips A.M., Uraizee S.A., Sakr A.M.: Pharm. Ind. 56, 579 (1994).
22. Charnay C., Lagerge S., Partyka S.: Prog. Colloid Polym. Sci. 115, 66 (2000).
23. Mutalik S., Usha N., Ranjith A.K., Umesh S., Musmade P., Anup N.: PDA. J. Pharm. Sci. Technol. 61, 362 (2007).
24. Dhumal R.S., Shimpi S.L., Paradkar A.R.: Acta Pharm. 57, 287 (2007).
25. Ventura C.A., Tommasini S., Falcone A,. Giannone I., Paolino D., Sdrafkakis V., Mondello M.R., Puglisi G.: Int. J. Pharm. 314, 37 (2006).
26. Kusum Devi V., Vijayalakshmip P., Avinash M.: Indian J. Pharm. Sci. 65, 542 (2003).
27. Ventura C.A., Giannone I., Paolino D., Pistarŕ V., Corsaro A., Puglisi G.: Eur. J. Med. Chem. 40, 624 (2005).
28. Motz S.A., Schaefer U.F., Balbach S., Eichinger T., Lehr C M.: Eur. J. Pharm. Biopharm. 66, 286 (2007).